肾炎康复片治疗肾小球肾炎的临床应用效果研究

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical application effect of Nephritis Rehabilitation Tablets in the treatment of glomerulonephritis.Methods Altogether 60 cases of glomerulonephritis patients who were treated in our hospital from February 23 in 2015 to February 23 in 2016 were selected and divided into the control group and the observation group according to the drawing lots,with 30 cases in each group.Valsartan and Nephritis Rehabilitation Tablets were applied respectively to the control group and observation group,then,patients′plasma albumin,cholesterol,creatinine,urea nitrogen and urine protein,the total effective rate,the incidence rate of adverse events and recurrence rate of the two groups were compared.Results The level of urea nitrogen,cholesterol,urine protein,the incidence rate of adverse events and the recurrence rate of the observation group were (6.12±0.36)mmol/L,(2.45±1.74)mmol/L,(0.18±0.12)g/24 h,3.33%and 3.33%,which were lower than those the control group′s (7.95±0.43)mmol/L,(3.95±1.43)mmol/L,(1.28±0.54)g/24 h,36.67%and 33.33%;the level of creatinine,plasma albumin and the total effective rate of the observation group were(63.45±2.13)μmol/L,(34.12±1.29)g/L and 96.67%,which were higher than those of the control group′s (61.74±1.32)μmol/L,(29.51±2.33)g/L and 63.33%,with significant difference(P＜0.05).Conclusion The treatment of glomerulonephritis patients with Nephritis Rehabilitation Tablets can improve the medication safety and long-term efficacy.

Key words： Nephritis Rehabilitation Tablet Glomerulonephritis Effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YANG Xue-hua
	LEI Xiao-qing2

Cite this article:

YANG Xue-hua,LEI Xiao-qing2. Study on clinical application effect of Nephritis Rehabilitation Tablets in the treatment of glomerulonephritis[J]. 中国当代医药, 2017, 24(28): 92-94.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I28/92

[1]	李艳锋，黄波，李俊，等.缬沙坦联合肾炎康复片治疗肾小球肾炎蛋白尿的疗效观察[J].湖南师范大学学报（医学版），2016，13（1）：23-25.
[2]	高聪普，白寿军，朱迎春，等.肾炎康复片治疗原发性局灶节段硬化肾小球肾炎的临床观察[J].中国当代医药，2016，23（29）：54-56.
[3]	Walsh M，Solomons N，Lisk L，et al.Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function：a subgroup analysis of the aspreva lupus management study[J].Am J Kidney Dis，2013，61（5）：710-715.
[4]	李治成，刘芳，张芮，等.缬沙坦联合肾炎康复片治疗女性肾小球肾炎蛋白尿的疗效观察[J].现代生物医学进展，2016，16（34）：6648-6651.
[5]	吴莹，何云.肾炎康复片联合氯沙坦钾治疗慢性肾小球肾炎的疗效及对血清白细胞诱素1、肿瘤坏死因子α和白细胞介素 33 的影响[J].医学综述，2016，22（21）：4296-4298，4305.
[7]	李君科.肾炎康复片治疗肾小球肾炎的应用效果及作用机制分析[J].当代医学，2017，23（3）：105-106.
[8]	彭心怡，夏智明，梅国斌，等.肾炎康复片联合缬沙坦治疗慢性肾小球肾炎疗效观察[J].海南医学，2015，26（3）：412-413.
[9]	桑晓荣.肾炎康复片联合依那普利治疗慢性肾小球肾炎疗效观察[J].实用中医药杂志，2015，31（7）：648-649.
[10]	李名波，孙智梅，任卓琴，等.氯沙坦钾片联合肾炎康复片治疗慢性肾小球肾炎蛋白尿的疗效观察[J].中国医院用药评价与分析，2017，17（1）：75-76.
[6]	Sekiuchi M，Kudo A，Nakabayashi K，et al.Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases：the results of studies using immunofluorescence，in situ hybridization，and immunoelectron microscopy[J].Clin Exp Nephrol，2012，16（6）：863-874.
[11]	张莲，艾金伟，李伟男，等.肾炎康复片联合西药治疗慢性肾小球肾炎系统评价[J].中国中医药信息杂志，2016，23（12）：44-50.
[12]	刘春姬.肾炎康复片治疗肾小球肾炎的临床效果及作用机制研究[J].黑龙江科学，2016，7（3）：20-21.
[13]	莫成宇.关于中西医结合治疗慢性肾小球肾炎临床研究[J].中西医结合心血管病电子杂志，2014，2（6）：72.
[14]	王蓓，汤绚丽.肾炎康复片联合缬沙坦治疗80例慢性肾小球肾炎的临床观察[J].中国现代医生，2015，53（6）：109-111.
[15]	邱冬豪，赵宁，王鸣.前列地尔合并肾康片对2型糖尿病肾病患者血清TNF-α、IL-6及IL-8水平的影响[J].中国现代医生，2017，55（13）：34-37.
[16]	沈明亮，林永明，陈英华，等.肾炎康复片联合缬沙坦治疗慢性肾小球肾炎的临床疗效观察[J].现代诊断与治疗，2015，26（22）：5106-5107.
[17]	金晓，凌含鹏，王文凤，等.肾炎康复片联合ARB类降压药治疗慢性肾炎的Meta分析[J].中国中西医结合肾病杂志，2016，17（2）：156-159.